Cunjie Chang

1.2k total citations
23 papers, 809 citations indexed

About

Cunjie Chang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Cunjie Chang has authored 23 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Cunjie Chang's work include RNA modifications and cancer (5 papers), RNA Research and Splicing (4 papers) and Epigenetics and DNA Methylation (3 papers). Cunjie Chang is often cited by papers focused on RNA modifications and cancer (5 papers), RNA Research and Splicing (4 papers) and Epigenetics and DNA Methylation (3 papers). Cunjie Chang collaborates with scholars based in China, United States and Singapore. Cunjie Chang's co-authors include Jun Yan, Wei Zhao, Li Yu, Ruimin Huang, Ji Zhou, Zhibo Hou, Chunhua Xu, Lan Shen, Jianxiang Chen and Duo Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Cunjie Chang

21 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cunjie Chang China	16	554	362	100	66	66	23	809
Yuyang Liu China	16	520 0.9×	263 0.7×	74 0.7×	86 1.3×	45 0.7×	29	805
Bo Lin China	16	521 0.9×	248 0.7×	183 1.8×	100 1.5×	73 1.1×	52	906
Xiaofeng Lai China	13	594 1.1×	347 1.0×	129 1.3×	64 1.0×	40 0.6×	21	878
Bei Xie China	17	473 0.9×	263 0.7×	182 1.8×	90 1.4×	113 1.7×	39	909
Deyao Shi China	16	377 0.7×	195 0.5×	115 1.1×	39 0.6×	57 0.9×	36	710
Sima Orouei Iran	16	571 1.0×	379 1.0×	167 1.7×	75 1.1×	39 0.6×	19	848
Naoshad Mohammad India	10	412 0.7×	305 0.8×	137 1.4×	82 1.2×	78 1.2×	11	668
Bikash Chandra Jena India	13	451 0.8×	236 0.7×	144 1.4×	50 0.8×	31 0.5×	24	667
Qin Fu China	18	707 1.3×	381 1.1×	147 1.5×	36 0.5×	40 0.6×	28	997

Countries citing papers authored by Cunjie Chang

Since Specialization

Citations

This map shows the geographic impact of Cunjie Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cunjie Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cunjie Chang more than expected).

Fields of papers citing papers by Cunjie Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cunjie Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cunjie Chang. The network helps show where Cunjie Chang may publish in the future.

Co-authorship network of co-authors of Cunjie Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Cunjie Chang. A scholar is included among the top collaborators of Cunjie Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cunjie Chang. Cunjie Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Qian, Yan Tong, Cunjie Chang, et al.. (2025). N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR ‐1236‐3p/ GPX2 Axis. Cancer Science. 116(12). 3326–3336.

Wang, Minmin, et al.. (2025). Alternative splicing: A key regulator in T cell response and cancer immunotherapy. Pharmacological Research. 215. 107713–107713. 1 indexed citations

Huang, J. S., Liang Xu, Ye Chen, et al.. (2025). Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma. Journal of Advanced Research. 82. 803–819.

Chang, Cunjie, et al.. (2024). Experimental Study on the Classification and Evolution of the Tip Cavitation Morphology in Axial Waterjet Pumps with Two Different Blade Numbers. Journal of Marine Science and Engineering. 12(11). 1898–1898. 4 indexed citations

Li, Qian, Meng Yao, Cunjie Chang, et al.. (2023). Kinesin family member 18B activates mTORC1 signaling via actin gamma 1 to promote the recurrence of human hepatocellular carcinoma. Oncogenesis. 12(1). 54–54. 5 indexed citations

Chen, Jianxiang, Yiting Qiao, Guo Chen, et al.. (2021). Salmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironment. Acta Pharmaceutica Sinica B. 11(10). 3165–3177. 49 indexed citations

Pan, Jinghua, Yiting Qiao, Congcong Chen, et al.. (2021). USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1. Cell Death and Disease. 12(11). 1051–1051. 51 indexed citations

Li, Qian, Fan Yang, Lina Li, et al.. (2021). Dysregulation of Wnt/β‐catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application. Cancer Science. 112(5). 1695–1706. 38 indexed citations

Dong, Heng, Cunjie Chang, Fan Yang, et al.. (2020). Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis. Biochemical Pharmacology. 182. 114266–114266. 33 indexed citations

10.

Chang, Cunjie, Jianghuai Liu, Wei He, et al.. (2017). A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression. Oncogene. 37(4). 415–426. 34 indexed citations

11.

Yan, Jun, Qing Zhang, Wei Zhao, et al.. (2015). Abstract 3517: Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis. Cancer Research. 75(15_Supplement). 3517–3517. 1 indexed citations

12.

Li, Yan, Duo Zhang, Xiaoyun Wang, et al.. (2015). Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer. Scientific Reports. 5(1). 12495–12495. 82 indexed citations

13.

Zhou, Ji, Hui Bi, Ping Zhan, et al.. (2014). Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival. Tumor Biology. 35(10). 9777–9785. 18 indexed citations

14.

Hou, Zhibo, Wei Zhao, Ji Zhou, et al.. (2014). A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival. The International Journal of Biochemistry & Cell Biology. 53. 380–388. 130 indexed citations

15.

Liu, Wei, Hongchao Cao, Ye Cheng, et al.. (2014). Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling. Nature Communications. 5(1). 5684–5684. 98 indexed citations

16.

Zhao, Wei, Cunjie Chang, Yangyan Cui, et al.. (2014). Steroid Receptor Coactivator-3 Regulates Glucose Metabolism in Bladder Cancer Cells through Coactivation of Hypoxia Inducible Factor 1α. Journal of Biological Chemistry. 289(16). 11219–11229. 48 indexed citations

17.

Zhou, Zizhang, Xia Yao, Ping Chen, et al.. (2014). Hedgehog signaling downregulates Suppressor of Fused through the HIB/SPOP-Crn axis in Drosophila. Cell Research. 24(5). 595–609. 23 indexed citations

18.

Wang, Xiaoyong, Yajie Song, Jing Wang, et al.. (2013). A platinum anticancer theranostic agent with magnetic targeting potential derived from maghemite nanoparticles. Chemical Science. 4(6). 2605–2605. 48 indexed citations

19.

Xu, Chunhua, Zhibo Hou, Ping Zhan, et al.. (2013). EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer. Medical Oncology. 30(4). 713–713. 39 indexed citations

20.

Chang, Cunjie, Wei Zhao, Bingxian Xie, et al.. (2013). Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling. Integrative Cancer Therapies. 13(3). 249–258. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact